desflurane has been researched along with remimazolam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hari, Y; Kakuta, N; Kato, T; Morio, A; Murakami, C; Narasaki, S; Satomi, S; Tanaka, K; Tsutsumi, YM | 1 |
| An, J; Liang, H; Yang, X | 1 |
| Jang, YN; Jeon, YG; Song, SW; Yoon, MW | 1 |
2 trial(s) available for desflurane and remimazolam
| Article | Year |
|---|---|
Remimazolam decreased the incidence of early postoperative nausea and vomiting compared to desflurane after laparoscopic gynecological surgery.
Topics: Antiemetics; Benzodiazepines; Desflurane; Double-Blind Method; Female; Gynecologic Surgical Procedures; Humans; Incidence; Laparoscopy; Postoperative Nausea and Vomiting; Prospective Studies | 2022 |
Quality of recovery in patients administered remimazolam versus those administered an inhalant agent for the maintenance of general anesthesia: a randomized control trial.
Topics: Anesthesia, General; Benzodiazepines; Desflurane; Female; Humans; Postoperative Nausea and Vomiting; Single-Blind Method | 2022 |
1 other study(ies) available for desflurane and remimazolam
| Article | Year |
|---|---|
Difficult to evaluate the effect of remimazolam.
Topics: Benzodiazepines; Desflurane; Female; Gynecologic Surgical Procedures; Humans; Incidence; Laparoscopy; Postoperative Nausea and Vomiting | 2022 |